Delivery Order SPE2DB22D1106-SPE2DB24FECY5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hemabate 250 mcg/mL ampules. The contract has a ceiling value of $1,811.65 and a completion date of September 13, 2023. It is a firm-fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., the parent company, which holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,586.36 firm fixed-price delivery order is for the supply of HEMABATE 250 MCG/ML AMPUL/ML, a pharmaceutical product, with an ultimate completion date of October 23, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award is for the delivery of HEMABATE 250 MCG/ML AMPUL/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $20,848.30 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 24, 2022 with a completion date of September 26, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the...
- The Defense Logistics Agency awarded a $2,119.75 delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/mL ampules, with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the...
- The Defense Logistics Agency issued a $2,156.10 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for Hemabate 250 mcg/mL ampuules, with an ultimate completion date of March 12, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs. The company holds a significant IDC with DLA Troop Support Medical...
- The Defense Logistics Agency issued a $1,402.56 delivery order to Amerisourcebergen Drug Corp on March 25, 2026, for Hemabate 250 mcg/ml ampules, with an ultimate completion date of March 26, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing...
- The Defense Logistics Agency issued a $1,550.86 delivery order to AmerisourceBergen Drug Corp on March 18, 2026, for HEMABATE 250 MCG/ML ampules, with ultimate completion on March 19, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing is...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,315.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide pharmaceutical products and medical supplies to support military treatment programs and facilities. The contract has a completion date of February 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $37,457.89 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide pharmaceutical products and medical supplies to military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, which has a potential value of $999,999,999.00 and a performance period...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $15,301.80 by the Defense Logistics Agency (DLA) Troop Support Medical. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FECY5Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,958.19 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a completion date of March 5, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 3/4/24 |